Foster City, CA, United States of America

Bryan Ka Ip Chan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 12.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Bryan Ka Ip Chan

Introduction

Bryan Ka Ip Chan is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic compounds aimed at treating serious diseases.

Latest Patents

Bryan holds 2 patents that focus on innovative therapeutic compounds and methods of use. His latest patents include:

1. **Therapeutic compounds and methods of use** - This disclosure relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

2. **Pyrazolo compounds and methods of use thereof** - This disclosure relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

Career Highlights

Bryan is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to focus on groundbreaking research that has the potential to impact the treatment of various diseases.

Collaborations

Throughout his career, Bryan has collaborated with talented professionals, including Jason R Zbieg and Paul Powell Beroza. These collaborations have fostered an environment of innovation and creativity, leading to advancements in therapeutic solutions.

Conclusion

Bryan Ka Ip Chan's contributions to the field of pharmaceuticals through his patents and work at Genentech, Inc. highlight his commitment to advancing medical science. His innovative approaches continue to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…